Lantern Pharma Inc(NASDAQ:LTRN) 
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on the development of precision oncology therapies using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant...
Website: http://www.lanternpharma.com
Founded: 2013
Full Time Employees: 4
CEO: Panna L. Sharma
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.10
H 3.25
L 2.91
C 2.99
V 47,293
10EMA 2.99
20EMA 2.99
60EMA 2.99
120EMA 2.99
250EMA 2.99